Home FDA Halts Sales At Gene-Scanning Firm 23andMe

FDA Halts Sales At Gene-Scanning Firm 23andMe

The Food and Drug Administration ordered Google-backed DNA testing service 23andMe to halt its genetic-scanning services until it can prove to the agency that its gene tests are accurate, the New York Times reports.

23andMe’s “personal genome service” purports to tell users whether they might be susceptible to diseases such as various types of cancer or how their body might respond to a particular drug. The FDA argues that the company hasn’t yet “analytically or clinically validated” its service for its intended uses.

Image via dullhunk on Flickr

About ReadWrite’s Editorial Process

The ReadWrite Editorial policy involves closely monitoring the tech industry for major developments, new product launches, AI breakthroughs, video game releases and other newsworthy events. Editors assign relevant stories to staff writers or freelance contributors with expertise in each particular topic area. Before publication, articles go through a rigorous round of editing for accuracy, clarity, and to ensure adherence to ReadWrite's style guidelines.

Get the biggest tech headlines of the day delivered to your inbox

    By signing up, you agree to our Terms and Privacy Policy. Unsubscribe anytime.

    Tech News

    Explore the latest in tech with our Tech News. We cut through the noise for concise, relevant updates, keeping you informed about the rapidly evolving tech landscape with curated content that separates signal from noise.

    In-Depth Tech Stories

    Explore tech impact in In-Depth Stories. Narrative data journalism offers comprehensive analyses, revealing stories behind data. Understand industry trends for a deeper perspective on tech's intricate relationships with society.

    Expert Reviews

    Empower decisions with Expert Reviews, merging industry expertise and insightful analysis. Delve into tech intricacies, get the best deals, and stay ahead with our trustworthy guide to navigating the ever-changing tech market.